Peso alla nascita, salute cardiovascolare e complicanze microvascolari in individui con diabete mellito
Yu Chaolun, Feng Anping, Zou Xia, Chen Siqi, Dai Lingyan, Cui Qingmei, Kuang Xiaojing, She Gaoli et al. ยท 2025
Abstract (in lingua originale)
Diabetes often leads to microvascular complications, including nephropathy, neuropathy, and retinopathy. Understanding the impact of early-life factors like birth weight and modifiable behaviors such as cardiovascular health (CVH) is essential for preventing these complications. We included 11,515 participants with diabetes but without microvascular complications at baseline from the UK Biobank Study. CVH was evaluated using the Lifeโs Essential 8 score. Independent and joint associations of birth weight and CVH with microvascular complications were analyzed using Cox proportional hazard models. Two-sample Mendelian randomization (MR) analyses estimated unconfounded associations between birth weight and microvascular complications. Over a median follow-up of 13.1 years, 3,010 microvascular complications occurred. Compared with normal birth weight (2.5โ4.0 kg), low birth weight (LBW; <2.5 kg) was associated with 15% higher risk of diabetic nephropathy (hazard ratio [HR], 1.15; 95% confidence interval [CI], 1.01 to 1.31), but not with neuropathy and retinopathy. High birth weight (>4.0 kg) was not associated with the risk of diabetic microvascular complications. MR analysis confirmed the association between LBW and nephropathy. Adherence to high CVH was associated with a reduced risk of microvascular complications compared to low CVH, regardless of birth weight. The HRs were 0.70 (95% CI, 0.59 to 0.84) for the LBW group and 0.74 (95% CI, 0.68 to 0.80) for the group with birth weight โฅ2.5 kg ( P for interaction=0.69). LBW was an independent risk factor for nephropathy among diabetic patients. However, the detrimental effects of LBW might be mitigated by improvement in CVH.
๐ฌ Chiedi a LEO di spiegartelo
Come leggerlo: รจ uno studio scientifico peer-reviewed. Le evidenze aiutano a capire i trend, ma un singolo studio non รจ una prescrizione: parlane col tuo diabetologo prima di cambiare dieta o terapia.